Label: DECONEX DMX- dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride tablet

  • NDC Code(s): 50991-740-01, 50991-740-02
  • Packager: Poly Pharmaceuticals, Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated July 9, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Drug Facts

    Active ingredients (in each tablet)

    Dextromethorphan HBr 17.5 mg

    Guaifenesin 400 mg

    Phenylephrine HCl 10 mg

    Purpose

    Cough Suppressant
    Expectorant
    Nasal Decongestant

  • Uses

    Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:

    • cough due to minor throat and bronchial irritation
    • helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes and make coughs more productive
    • nasal congestion
    • reduces swelling of nasal passages
  • Warnings

    Do not exceed recommended dosage.

    Do not use this product

    • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug.  If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

    Ask a doctor before use if you have

    • a cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema
    • a cough that occurs with too much phlegm (mucus)
    • heart disease
    • high blood pressure
    • thyroid disease
    • diabetes
    • trouble urinating due to an enlarged prostate gland

    Stop use and ask a doctor if

    • nervousness, dizziness, or sleeplessness occur
    • cough or nasal congestion persists for more than 1 week, tends to recur, or is accompanied by a fever, rash, or persistent headache.  A persistent cough may be a sign of a serious condition.
    • new symptoms occur

    If pregnant or breast feeding, ask a health professional before use.

    Keep out of reach of children.  In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    Do not exceed recommended dosage.

    Adults and children 12
    years of age and over:

    		1 tablet every 4 hours,
    not to exceed 6 tablets
    in 24 hours
    Children 6 to under 12
    years of age:

    		1/2 tablet every 4 hours,
    not to exceed 3 tablets
    in 24 hours
    Children under 6 years
    of age:
    		Consult a physician.


  • Other information

    Store at 15°- 30° C (59°- 86° F).

    Supplied in a tight, light-resistant container with a child-resistant cap.

    Deconex DMX Tablets are orange, oblong, capsule-shaped, scored tablets, debossed "POLY" bisect "730" on one side and blank on the other side.

  • Inactive ingredients

    Colloidal Silicon Dioxide, Croscarmellose Sodium, D&C Yellow #10 Aluminum Lake, FD&C Yellow #6 Aluminum Lake, Hypromellose, Maltodextrin, Povidone, Silicified Microcrystalline Cellulose, and Stearic Acid.

  • Questions? Comments?

    Call 1-800-882-1041.

    Manufactured for:

    Poly Pharmaceuticals

    Huntsville, AL

    1(800) 882-1041

    Rev: 06/19

  • Product Packaging

    The packaging below represents the labeling currently used.

    Principal display panel and side panel for 100 tablets label:

    NDC 50991-740-01



    DECONEX DMX

    TABLETS

    COUGH SUPPRESSANT · EXPECTORANT

    NASAL DECONGESTANT

    Each tablet contains:

    Dextromethorphan HBr........................17.5 mg

    Guaifenesin......................................400 mg

    Phenylephrine HCl..............................10 mg

    Tamper evident by foil seal under cap.

    Do not use if foil seal is broken or missing.

    Distributed by:

    Poly Pharmaceuticals
    Huntsville, AL

    100 tablets

    Rev. 06-19

    labelback

  • INGREDIENTS AND APPEARANCE
    DECONEX  DMX
    dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:50991-740
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DEXTROMETHORPHAN HYDROBROMIDE (UNII: 9D2RTI9KYH) (DEXTROMETHORPHAN - UNII:7355X3ROTS) DEXTROMETHORPHAN HYDROBROMIDE17.5 mg
    GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN400 mg
    PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE10 mg
    Inactive Ingredients
    Ingredient NameStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    HYPROMELLOSES (UNII: 3NXW29V3WO)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    POVIDONE (UNII: FZ989GH94E)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    Product Characteristics
    ColororangeScore2 pieces
    ShapeCAPSULESize17mm
    FlavorImprint Code POLY;730
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:50991-740-0212 in 1 CARTON06/01/2019
    11 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:50991-740-01100 in 1 BOTTLE; Type 0: Not a Combination Product06/01/2019
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01206/01/2019
    Labeler - Poly Pharmaceuticals, Inc. (198449894)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!